Study of the Etiology, Clinical Features and Short Term Outcome of Acquired Hemolytic Anemia in Hospitalized Adult Patients with Non-Neoplastic Disease
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hemolytic Anemia
- Sponsor
- Sohag University
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- intensive care unit admission of the patients due to progression of the disease complications.
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
the goal of the study is to identify the most common etiological factors and analyze the clinical presentations and laboratory findings in hospitalized patients with acquired hemolytic anemia associated with non-neoplastic diseases.
And to evaluate short-term outcomes, including morbidity and mortality rates, and to determine correlations between specific etiological factors and patient outcomes in these cases.
Investigators
Ahmed Elsayed Mahmoud
resident doctor
Sohag University
Eligibility Criteria
Inclusion Criteria
- •Adults aged 18 years and older.
- •Patients diagnosed with acquired hemolytic anemia.
- •Patients must be hospitalized in the Internal Medicine department at the time of diagnosis of acquired hemolytic anemia during the study period
- •Patients (or their legal representatives) must provide informed
Exclusion Criteria
- •Patients with underlying neoplastic diseases.
- •Patients with hereditary hemolytic anemia.
- •Patients or their representatives who do not consent to participate in the study.
Outcomes
Primary Outcomes
intensive care unit admission of the patients due to progression of the disease complications.
Time Frame: through study completion, an average of 6 months
Primary outcome will be ICU admission due to progression of the disease complications.
Secondary Outcomes
- mortality within duration of hospital admission(through study completion, an average of 6 months)